Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP279697.RA7wIp2kLcccLKhr8lxNvmY8cXhX4MbFiNQx3YfUn5QN8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP279697.RA7wIp2kLcccLKhr8lxNvmY8cXhX4MbFiNQx3YfUn5QN8130_assertion type Assertion NP279697.RA7wIp2kLcccLKhr8lxNvmY8cXhX4MbFiNQx3YfUn5QN8130_head.
- NP279697.RA7wIp2kLcccLKhr8lxNvmY8cXhX4MbFiNQx3YfUn5QN8130_assertion description "[We examined the expression levels of mRNA for multidrug resistance 1 (MDR1), multidrug resistance-associated protein (MRP), human canalicular multispecific organic anion transporter (cMOAT), lung resistance-related protein (LRP), topoisomerase IIalpha, beta (Topo IIalpha, beta) and topoisomerase I (Topo I) genes in human head and neck squamous cell carcinoma (HNSCC) specimens and mucosa (HNM) specimens, to elucidate their roles in relation to the biological characteristics and drug resistance in vivo.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP279697.RA7wIp2kLcccLKhr8lxNvmY8cXhX4MbFiNQx3YfUn5QN8130_provenance.
- NP279697.RA7wIp2kLcccLKhr8lxNvmY8cXhX4MbFiNQx3YfUn5QN8130_assertion evidence source_evidence_literature NP279697.RA7wIp2kLcccLKhr8lxNvmY8cXhX4MbFiNQx3YfUn5QN8130_provenance.
- NP279697.RA7wIp2kLcccLKhr8lxNvmY8cXhX4MbFiNQx3YfUn5QN8130_assertion SIO_000772 10744048 NP279697.RA7wIp2kLcccLKhr8lxNvmY8cXhX4MbFiNQx3YfUn5QN8130_provenance.
- NP279697.RA7wIp2kLcccLKhr8lxNvmY8cXhX4MbFiNQx3YfUn5QN8130_assertion wasDerivedFrom befree-2016 NP279697.RA7wIp2kLcccLKhr8lxNvmY8cXhX4MbFiNQx3YfUn5QN8130_provenance.
- NP279697.RA7wIp2kLcccLKhr8lxNvmY8cXhX4MbFiNQx3YfUn5QN8130_assertion wasGeneratedBy ECO_0000203 NP279697.RA7wIp2kLcccLKhr8lxNvmY8cXhX4MbFiNQx3YfUn5QN8130_provenance.